Cassava Sciences (SAVA) announced that Angelique Bordey, PhD, has joined the Company as Senior Vice President, SVP, Neuroscience, while continuing her tenured academic position at Yale School of Medicine on a part time basis.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SAVA:
- Cassava Sciences Announces Leadership Changes Amid Strategic Shift
- Cassava Sciences chief medical officer James Kupiec to retire
- Biotech Alert: Searches spiking for these stocks today
- Cassava Sciences announces Phase 3 REFOCUS-ALZ did not meet primary endpoint
- Cassava Sciences to resume trading at 8:35 am ET